Safety and effectiveness of eculizumab in Japanese patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: interim analysis of post-marketing surveillance data

被引:0
|
作者
Nakashima, I. [1 ]
Hoshino, Y. [2 ]
Okamura, K. [2 ]
Kikui, H. [2 ]
机构
[1] Tohoku Med & Pharmaceut Univ, Div Neurol, Sendai, Miyagi, Japan
[2] Alex Pharma GK, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P973
引用
收藏
页码:791 / 792
页数:2
相关论文
共 50 条
  • [21] Conus involvement and leptomeningeal enhancement in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: A case report
    Li Safadi, Amy
    Myers, Cory J.
    Hu, Nancy N.
    Osborne, Benjamin
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [22] Long-term disability progression in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a retrospective analysis of 101 patients
    Uzawa, Akiyuki
    Mori, Masahiro
    Masuda, Hiroki
    Uchida, Tomohiko
    Muto, Mayumi
    Ohtani, Ryohei
    Aoyama, Shinji
    Kuwabara, Satoshi
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (07): : 626 - 629
  • [24] Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
    Pittock, S. J.
    Berthele, A.
    Fujihara, K.
    Kim, H. J.
    Levy, M.
    Palace, J.
    Nakashima, I.
    Terzi, M.
    Totolyan, N.
    Viswanathan, S.
    Wang, K. -C.
    Pace, A.
    Fujita, K. P.
    Armstrong, R.
    Wingerchuk, D. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (07): : 614 - 625
  • [25] Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
    Patrick Schindler
    Ulrike Grittner
    Johanna Oechtering
    David Leppert
    Nadja Siebert
    Ankelien S. Duchow
    Frederike C. Oertel
    Susanna Asseyer
    Joseph Kuchling
    Hanna G. Zimmermann
    Alexander U. Brandt
    Pascal Benkert
    Markus Reindl
    Sven Jarius
    Friedemann Paul
    Judith Bellmann-Strobl
    Jens Kuhle
    Klemens Ruprecht
    Journal of Neuroinflammation, 18
  • [26] Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder associated with esophageal cancer
    Kon, Tomoya
    Ueno, Tatsuya
    Suzuki, Chieko
    Nunomura, Jinichi
    Igarashi, Shohei
    Sato, Tsugumi
    Tomiyama, Masahiko
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 309 : 38 - 40
  • [27] Clinical Characteristics of Chinese Male Patients with Aquaporin-4 Antibody-Positive Late-Onset Neuromyelitis Optica Spectrum Disorder
    Liang, Jie
    Liu, Jia
    Gu, Meifeng
    Zhu, Cansheng
    Xu, Xiaofeng
    Fan, Rong
    Peng, Fuhua
    Jiang, Ying
    NEUROIMMUNOMODULATION, 2021, 28 (02) : 61 - 67
  • [28] Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
    Schindler, Patrick
    Grittner, Ulrike
    Oechtering, Johanna
    Leppert, David
    Siebert, Nadja
    Duchow, Ankelien S.
    Oertel, Frederike C.
    Asseyer, Susanna
    Kuchling, Joseph
    Zimmermann, Hanna G.
    Brandt, Alexander U.
    Benkert, Pascal
    Reindl, Markus
    Jarius, Sven
    Paul, Friedemann
    Bellmann-Strobl, Judith
    Kuhle, Jens
    Ruprecht, Klemens
    JOURNAL OF NEUROINFLAMMATION, 2021, 18 (01)
  • [29] Subgroup analyses from the Phase 3 PREVENT study in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
    Pittock, S.
    Berthele, A.
    Fujihara, K.
    Kim, H. J.
    Levy, M.
    Palace, J.
    Terzi, M.
    Totolyan, N.
    Viswanathan, S.
    Wang, K. -C.
    Pace, A.
    Fujita, K. P.
    Yountz, M.
    Armstrong, R.
    Wingerchuk, D. M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 289 - 290
  • [30] Genetic analysis of the aquaporin-4 gene for anti-AQP4 antibody-positive neuromyelitis optica in a Japanese population
    Ogasawara, Mikihide
    Meguro, Akira
    Sakai, Tsutomu
    Mizuki, Nobuhisa
    Takahashi, Toshiyuki
    Fujihara, Kazuo
    Tsuneoka, Hiroshi
    Shikishima, Keigo
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2016, 60 (03) : 198 - 205